Table 13.
Reference; study confidence; N | Age at outcome measure | Median maternal exposures | Exposure IQR (or as specified) | Motor overall effect estimate β (95% CI) | Motor in boys β (95% CI) | Motor in girls β (95% CI) |
---|---|---|---|---|---|---|
Polanska et al. (2014); medium; 150 | 2 yr | 19 ng/mL | 336 (95th) | 0.1 (−1.5, 1.8) | NR | NR |
Balalian et al., 2019; medium; 209 | 11 yr | 131 ng/mL | 67–302 | NR | 0.5 (−0.5,1.5) | −1.2 (−2.4,−0.1)* |
Téllez-Rojo et al. (2013); medium; 135 | 2–3 yr | 138 ng/mL (GM) | NR | 0.02 (−1.0, 1.0) | 0.1 (−1.3,1.5) | 0.3 (−1.1,1.7) |
Doherty et al. (2017); medium; 258 | 1–3 yr | 172 ng/mL | 3372 (95th) | 0.4 (−0.7,1.5) | 0.2 (−1.3,1.6) | 0.6 (−1.1,2.3) |
Gascon et al. (2015); high; 367 | 1 yr | 403 μg/g | 199‒756 | −1.2 (−2.8,0.6)^ | −1.2 (−3.7,1.2)^ | −0.2 (−3.6,1.3)^ |
4 yr | 0.6 (−1.0,2.1)^ | 2.0 (−0.4,4.4)^ | 0.5 (−1.8,2.7)^ |
One low confidence study (Kim et al., 2018) not shown in table because results were incompletely reported.
All studies used 1n-transformed exposure and βs represent 1 ln-unit increase, except for Gascon, which used log2-transformation and β represent doubling of exposure.
Results that support an adverse association are shaded. This represents one or more of the following: p < 0.05, β ≥ 0.5, or exposure-response trend across categories of exposure. NR = not reported. GM = geometric mean.
p < 0.05.
Upon request, author provided re-calculated results with 1n-transformed exposure and β representing a ln-unit increase, to improve comparability with other studies.